Presenter: Sara Litvak, BCBA
Private equity firms are increasingly investing in U.S healthcare, specifically Applied Behavior Analysis. While supporters argue it increases innovation, access-to-access care and reimbursement rates, critics say it can harm clinical practices and reduce the quality of care. While, Healthcare regulations and laws prevent private equity firms prevent private equity firms from harming patients to earn a profit. This offers some protection – and in some cases, better treatment may actually generate more income. This presentation will explore the dynamics emerging from the entry of private and provides some suggestions in providing ethical service delivery to mitigate potential drawbacks.